All together, our data suggest that among the two family members studied here, SIRT2 exhibits strong tumor suppressive properties upon CR regardless of the p53 genetic background, consistent with a role for SIRT2 in mediating the cancer preventive effect of CR. The gene discussed is TP53; the disease is neoplasm.